Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results

Last Modified: 9/19/2008 First Published: 1/1/2001


1.		Phase III Randomized Chemoprevention Study of Selenium in Participants With Previously Resected Stage I Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				18 and over				NCI				ECOG-5597 CAN-NCIC-BR16, CALGB-79803, NCCTG-E5597, SWOG-E5597, NCI-P00-0176, NCT00008385, BR16

Last Modified: 9/17/2008 First Published: 2/20/2004


2.		Phase III Randomized Study of Selenium in Patients With Adenomatous Colorectal Polyps

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				40 to 80				NCI				UARIZ-00-0430-01 UARIZ-HSC-00142, NCT00078897

First Published: 6/25/2008


3.		Phase III Study of the Effect of Vitamin E and/or Selenium on Adenomatous Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Natural history/Epidemiology, Prevention				Active				50 and over				NCI				SWOG-S0000D S0000D, SWOG-S0000D, NCT00706121

Last Modified: 8/29/2008 First Published: 8/5/2008


4.		Phase III Randomized Study of Selenium in Patients With Non-Muscle-Invasive Transitional Cell Carcinoma of the Bladder at Risk for Recurrence

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				UZG-CUL-UHG-Non-Invasive Bladder Cancer CUL-UHG-Non-Invasive Bladder Cancer, EU-20870, NCT00729287


5.		The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				18 and over				Other				UHN REB 03-0741-C NCT00188604


6.		Dietary Intervention in Follicular Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				Dietary intervention FL NCT00455416


7.		Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Diagnostic, Treatment				Active				18 and over				Other				07-0580-B NCT00744549

First Published: 9/11/2008


8.		Phase II Randomized Study of Selenium in Patients With Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Under 85				NCI				UARIZ-97-0395 UARIZ-HSC-97-57, Watchful Waiting, NCT00752739


9.		Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				Not specified				Other				WCRF 2004/21 CMO nr. 2007/003, SePros 2006/02, NL14694.091.07, NCT00446901


10.		Soy, Selenium and Breast Cancer Risk

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Prevention				Active				35 to 50				Other				R14697 07/Q0101/10, NCT00555386

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute